Medtronic plc (MDT) stock forecast and price target
Price $102.86 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($102.86)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends April 30, 2027 | $5.98 | +8.1% | $39.0B |
| Next fiscal year ends April 30, 2028 | $6.41 | +7.2% | $40.4B |
| Quarter after ends January 31, 2027 | $1.42 | +4.7% | $9.5B |
Consensus of the analysts covering Medtronic, updated daily. In the last 30 days 2 estimates were raised and 2 lowered.
Our model vs. Wall Street
Analysts see 2.1% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Medtronic’s intrinsic value about 16% below today’s market value, and it scores 2.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Medtronic stock price target?
The average 12-month target from 26 analysts is $105.00, 2.1% above the current price of $102.86 Targets range from $85.00 to $121.00.
Is Medtronic a buy according to analysts?
The consensus rating is “Buy” (2 strong buy, 17 buy, 11 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Medtronic expected to earn?
Analysts expect EPS of $5.98 for the fiscal year ending April 30, 2027 and $6.41 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.